A
Amylyx Pharmaceuticals, Inc. (AMLX)
NMS – Real Time Price. Currency in USD
14.44
-0.44 (-2.96%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
14.44
-0.44 (-2.96%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $229.1M significantly exceed its total debt $5.6M, ensuring strong financial flexibility
Total current assets $285.0M exceed Total current liabilities $16.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (-0.8), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$36.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 17.85 | 2.52 | 10 | |
| Quick ratio | 17.85 | 1.78 | 10 | |
| Debt to Equity | 0.02 | -0.80 | 9.0 | |
| Debt to Assets | 0.02 | 0.73 | 9.0 | |
| Interest coverage | N/A | -13.90 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 22M | 381M | 87M | N/A | N/A |
| Gross Profit | 19M | 354M | -38M | -525K | -467K |
| Operating Income | -201M | 39M | -256M | -153M | -159M |
| Net Income | -198M | 49M | -302M | -145M | -150M |
| EBITDA | -201M | 40M | -255M | -153M | -159M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 24.25 | 5.5 |
| Next quarter | N/A | 8.56 | 3.5 |
| Current year | N/A | 6.8 | 3.0 |
| Next year | N/A | 9.95 | 3.5 |
| Weighted average score | 3.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -25.1 | -23.32 | -31.76 | 3.3 |
| Y/Y | 999 | -14.96 | 11.9 | 7.41 | 5.8 |
| 3y average | 478.63 | -178.5 | -182.24 | -513.06 | 3.3 |
| 5y average | 1815.95 | -153.81 | -118.02 | -357.16 | 3.3 |
| Weighted average score | 3.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |